Thomas William LeBlanc, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member of the Duke Cancer Institute
Campus mail 2424 Erwin Road, Suite 602, Durham, NC 27705
Phone (919) 668-2115
Email address thomas.leblanc@duke.edu

Dr. LeBlanc is a medical oncologist, palliative care physician, and patient experience researcher.  His clinical practice focuses on the care of patients with hematologic malignancies, with a particular emphasis on myeloid conditions and acute leukemias including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs / MPDs, CML).  He is an active member of the inpatient non-transplant hematologic malignancies care team, based on the 9100 ward of Duke University Hospital.

His research interests converge on common issues faced by people with cancer, particularly those with high-risk or relapsed/refractory hematologic malignancies. Issues of symptom burden and quality of life are of central importance in these settings, and may lead patients to face difficult decision-making scenarios. Dr. LeBlanc’s research explores the experience of patients and families in these settings, and aims to improve patients experiences living with blood cancers, including the involvement of specialist palliative care services to provide an extra layer of support along with their comprehensive cancer care, to improve symptom management and quality of life.

Dr. LeBlanc is the recipient of a Junior Career Development Award grant from the National Palliative Care Research Center (NPCRC), a Sojourns Scholars Leadership Award from the Cambia Health Foundation, and a Mentored Research Scholar Grant from the American Cancer Society. These grants have funded efforts to better understand the experience of patients living with AML, including studies of symptom burden, quality of life, distress, understanding of prognosis, and treatment decision-making. This work has been mentored by a team of expert researchers, including Drs. Amy Abernethy, James Tulsky, Karen Steinhauser, Kathryn Pollak, and Peter Ubel.  Dr. LeBlanc's work in palliative care research led to his recognition as an "Inspirational Leader under 40" by the American Academy of Hospice and Palliative Medicine (AAHPM), and "fellow" status from the Academy in 2016. Dr. LeBlanc was the 2017-18 Chair of the ASCO Ethics Committee, and Chairs the Scientific Review Committee of the NIH/NINR-funded Palliative Care Research Cooperative Group (PCRC; www.palliativecareresearch.org). He has served on various national guideline panels for AML, and for palliative/supportive care issues in oncology. 

He completed residency training in Internal Medicine at Duke, as well as fellowships in Medical Oncology and Hospice and Palliative Medicine.  He graduated from the Duke University School of Medicine, also earning a Master of Arts degree in Philosophy during that time, and served as Chief Medical Resident at the Durham VA Medical Center in 2010-11.  He holds board certifications in Medical Oncology, and in Hospice and Palliative Medicine.  He is actively involved with teaching of medical students and housestaff at Duke, particularly with regards to issues of patient-doctor communication, and is mentoring several Duke trainees on research projects.

Education and Training

  • Fellow, Medical Oncology, Duke University School of Medicine, 2012 - 2013
  • Fellowship, Hospice And Palliative Medicine, Duke University School of Medicine, 2011 - 2012
  • Chief Medical Resident, Duke University School of Medicine, 2010 - 2011
  • Resident, Duke University School of Medicine, 2007 - 2009
  • Intern, Duke University School of Medicine, 2006 - 2007
  • M.D., Duke University, 2006

Publications

LeBlanc, Matthew R., Thomas W. LeBlanc, Ashley Leak Bryant, Kathryn I. Pollak, Donald E. Bailey, and Sophia K. Smith. “A Qualitative Study of the Experiences of Living With Multiple Myeloma.” Oncol Nurs Forum 48, no. 2 (March 1, 2021): 151–60. https://doi.org/10.1188/21.ONF.151-160.

PMID
33600390
Full Text

Tarnasky, Aaron M., Jesse D. Troy, and Thomas W. LeBlanc. “The patient experience of ABVD treatment in Hodgkin lymphoma: a retrospective cohort study of patient-reported distress.” Support Care Cancer, February 11, 2021. https://doi.org/10.1007/s00520-021-06044-9.

PMID
33576877
Full Text

El-Jawahri, Areej, Thomas W. LeBlanc, Alison Kavanaugh, Jason A. Webb, Vicki A. Jackson, Toby C. Campbell, Nina O’Connor, et al. “Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial.” Jama Oncol 7, no. 2 (February 1, 2021): 238–45. https://doi.org/10.1001/jamaoncol.2020.6343.

PMID
33331857
Full Text

Rao, Vinay B., Emmanuelle Belanger, Pamela C. Egan, Thomas W. LeBlanc, and Adam J. Olszewski. “Early Palliative Care Services and End-of-Life Care in Medicare Beneficiaries with Hematologic Malignancies: A Population-Based Retrospective Cohort Study.” J Palliat Med 24, no. 1 (January 2021): 63–70. https://doi.org/10.1089/jpm.2020.0006.

PMID
32609039
Full Text

Shah, Anne, Allison Petrilla, Mayvis Rebeira, Joseph Feliciano, Julie Lisano, and Thomas W. LeBlanc. “Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis.” Clin Lymphoma Myeloma Leuk 21, no. 1 (January 2021): e1–9. https://doi.org/10.1016/j.clml.2020.07.011.

PMID
33184000
Full Text

Le, Hannah, Kellie Ryan, Svea K. Wahlstrom, Martine C. Maculaitis, Oliver Will, Emily Mulvihill, and Thomas W. LeBlanc. “Oncologist and Patient Preferences for Novel Agents in First-Line Treatment for Chronic Lymphocytic Leukemia: Commonalities and Disconnects.” Patient Prefer Adherence 15 (2021): 99–110. https://doi.org/10.2147/PPA.S289139.

PMID
33519195
Full Text

Kwekkeboom, Kristine, Ronald C. Serlin, Sandra E. Ward, Thomas W. LeBlanc, Adeboye Ogunseitan, and James Cleary. “Revisiting patient-related barriers to cancer pain management in the context of the US opioid crisis.” Pain, December 14, 2020. https://doi.org/10.1097/j.pain.0000000000002173.

PMID
33337597
Full Text

Navari, Rudolph M., Kathryn J. Ruddy, Thomas W. LeBlanc, Ryan Nipp, Rebecca Clark-Snow, Lee Schwartzberg, Gary Binder, et al. “Avoidable acute care use associated with nausea and vomiting among patients receiving highly emetogenic chemotherapy or oxaliplatin.” Oncologist, December 1, 2020. https://doi.org/10.1002/onco.13620.

PMID
33289268
Full Text

Loh, Kah Poh, Mazie Tsang, Thomas W. LeBlanc, Anthony Back, Paul R. Duberstein, Supriya Gupta Mohile, Ronald M. Epstein, et al. “Decisional involvement and information preferences of patients with hematologic malignancies.” Blood Adv 4, no. 21 (November 10, 2020): 5492–5500. https://doi.org/10.1182/bloodadvances.2020003044.

PMID
33166406
Full Text

Pages